These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 39000110)
21. Acetylcysteine synergizes PD-1 blockers against colorectal cancer progression by promoting TCF1 Zhou W; Qu M; Yue Y; Zhong Z; Nan K; Sun X; Wu Q; Zhang J; Chen W; Miao C Cell Commun Signal; 2024 Oct; 22(1):503. PubMed ID: 39420342 [TBL] [Abstract][Full Text] [Related]
22. [Pexidartinib inhibits the aggregation of monocytes into tumor microenvironment and reduces the number of M2 tumor-associated macrophages]. Li X; Jue L; Wang S; Pang X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Apr; 35(4):307-312. PubMed ID: 31167689 [TBL] [Abstract][Full Text] [Related]
23. Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model. Yorita N; Yuge R; Takigawa H; Ono A; Kuwai T; Kuraoka K; Kitadai Y; Tanaka S; Chayama K Cancer Lett; 2021 Feb; 498():111-120. PubMed ID: 33129954 [TBL] [Abstract][Full Text] [Related]
24. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma. Park DJ; Sung PS; Lee GW; Cho S; Kim SM; Kang BY; Hur W; Yang H; Lee SK; Lee SH; Jung ES; Seo CH; Ahn J; Choi HJ; You YK; Jang JW; Bae SH; Choi JY; Yoon SK Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946835 [TBL] [Abstract][Full Text] [Related]
25. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Zhang A; Qian Y; Ye Z; Chen H; Xie H; Zhou L; Shen Y; Zheng S Cancer Med; 2017 Feb; 6(2):463-470. PubMed ID: 28097809 [TBL] [Abstract][Full Text] [Related]
26. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma. Valero JG; Matas-Céspedes A; Arenas F; Rodriguez V; Carreras J; Serrat N; Guerrero-Hernández M; Yahiaoui A; Balagué O; Martin S; Capdevila C; Hernández L; Magnano L; Rivas-Delgado A; Tannheimer S; Cid MC; Campo E; López-Guillermo A; Colomer D; Pérez-Galán P Leukemia; 2021 Sep; 35(9):2635-2649. PubMed ID: 33731849 [TBL] [Abstract][Full Text] [Related]
27. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC. Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750 [TBL] [Abstract][Full Text] [Related]
28. IR-780 Dye-based Targeting of Cancer-associated Fibroblasts Improves Cancer Immunotherapy by Increasing Intra-tumoral T Lymphocytes Infiltration. Yang W; Chen Z; Qu L; Zhang C; Chen H; Zheng J; Chen W; Tan X; Shi C Curr Cancer Drug Targets; 2024; 24(6):642-653. PubMed ID: 38310462 [TBL] [Abstract][Full Text] [Related]
29. High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway. Wen Z; Sun H; Zhang Z; Zheng Y; Zheng S; Bin J; Liao Y; Shi M; Zhou R; Liao W Cancer Commun (Lond); 2023 May; 43(5):562-581. PubMed ID: 37031362 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer. Min AKT; Mimura K; Nakajima S; Okayama H; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Saze Z; Momma T; Ohki S; Kono K Cancer Immunol Immunother; 2021 Feb; 70(2):289-298. PubMed ID: 32705303 [TBL] [Abstract][Full Text] [Related]
31. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer. Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072 [TBL] [Abstract][Full Text] [Related]
32. The active fraction of Garcinia yunnanensis suppresses the progression of colorectal carcinoma by interfering with tumorassociated macrophage-associated M2 macrophage polarization in vivo and in vitro. Sui H; Tan H; Fu J; Song Q; Jia R; Han L; Lv Y; Zhang H; Zheng D; Dong L; Wang S; Li Q; Xu H FASEB J; 2020 Jun; 34(6):7387-7403. PubMed ID: 32283574 [TBL] [Abstract][Full Text] [Related]
33. Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression. Gu X; Zhu Y; Su J; Wang S; Su X; Ding X; Jiang L; Fei X; Zhang W Redox Biol; 2024 Aug; 74():103209. PubMed ID: 38861833 [TBL] [Abstract][Full Text] [Related]
34. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer. Zhang R; Qi F; Zhao F; Li G; Shao S; Zhang X; Yuan L; Feng Y Cell Death Dis; 2019 Mar; 10(4):273. PubMed ID: 30894509 [TBL] [Abstract][Full Text] [Related]
35. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287 [TBL] [Abstract][Full Text] [Related]
36. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis. Kobayashi H; Gieniec KA; Lannagan TRM; Wang T; Asai N; Mizutani Y; Iida T; Ando R; Thomas EM; Sakai A; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Ng JQ; Goyne J; Radford G; Lawrence MJ; Sammour T; Hayakawa Y; Klebe S; Shin AE; Asfaha S; Bettington ML; Rieder F; Arpaia N; Danino T; Butler LM; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Takahashi M; Wang TC; Enomoto A; Woods SL; Worthley DL Gastroenterology; 2022 Mar; 162(3):890-906. PubMed ID: 34883119 [TBL] [Abstract][Full Text] [Related]
37. Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells. Rao G; Latha K; Ott M; Sabbagh A; Marisetty A; Ling X; Zamler D; Doucette TA; Yang Y; Kong LY; Wei J; Fuller GN; Benavides F; Sonabend AM; Long J; Li S; Curran M; Heimberger AB Clin Cancer Res; 2020 Sep; 26(17):4699-4712. PubMed ID: 32554515 [TBL] [Abstract][Full Text] [Related]
38. CD133-containing microvesicles promote cancer progression by inducing M2-like tumor-associated macrophage polarization in the tumor microenvironment of colorectal cancer. Kim SY; Park S; Kim S; Ko J Carcinogenesis; 2024 May; 45(5):300-310. PubMed ID: 38085813 [TBL] [Abstract][Full Text] [Related]
39. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression. Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612 [TBL] [Abstract][Full Text] [Related]
40. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages. Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]